{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:06:09Z","timestamp":1789718769691,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018512","name":"University of Hradec Kralove","doi-asserted-by":"publisher","award":["PrF UHK 2201\/2025-2026"],"award-info":[{"award-number":["PrF UHK 2201\/2025-2026"]}],"id":[{"id":"10.13039\/100018512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0208"],"award-info":[{"award-number":["P1-0208"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["GF23-42701 L"],"award-info":[{"award-number":["GF23-42701 L"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["N1-0277"],"award-info":[{"award-number":["N1-0277"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["DEC-2021\/43\/I\/NZ7\/00342"],"award-info":[{"award-number":["DEC-2021\/43\/I\/NZ7\/00342"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108998","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:06:23Z","timestamp":1758056783000},"page":"108998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Transforming ureas into carbamates: From allosteric p38\u03b1 MAPK ligands to dual BChE\/p38\u03b1 MAPK inhibitors"],"prefix":"10.1016","volume":"165","author":[{"given":"Svit Ferjan\u010di\u010d","family":"Benetik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u017ee","family":"Meden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damijan","family":"Knez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mastnak-Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Ko\u0161ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Pi\u0161lar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Andrys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Mus\u00edlek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Detka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Sa\u0142at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Obreza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108998_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108998_bb0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-023-02897-5","article-title":"Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum","volume":"20","author":"Gamage","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bioorg.2025.108998_bb0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajpath.2015.10.010","article-title":"Plaque-associated local toxicity increases over the clinical course of Alzheimer disease","volume":"186","author":"Serrano-Pozo","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108998_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108748","article-title":"Dual inhibition of butyrylcholinesterase and p38\u03b1 mitogen-activated protein kinase: a new approach for the treatment of Alzheimer\u2019s disease","volume":"264","author":"Ferjan\u010di\u010d Benetik","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.108998_bb0030","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer\u2019s disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.nbd.2017.08.019","article-title":"Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer\u2019s disease","volume":"108","author":"Iulita","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioorg.2025.108998_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.108998_bb0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jnc.14945","article-title":"Soluble a\u03b2 oligomers and protofibrils induce NLRP3 inflammasome activation in microglia","volume":"155","author":"Lu\u010di\u016bnait\u0117","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0050","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2025.108998_bb0055","doi-asserted-by":"crossref","first-page":"eabl8809","DOI":"10.1126\/sciadv.abl8809","article-title":"Alzheimer\u2019s disease: ablating single master site abolishes tau hyperphosphorylation","volume":"8","author":"Stefanoska","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioorg.2025.108998_bb0060","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1074\/jbc.M115.695916","article-title":"Deficiency of neuronal p38\u03b1 MAPK attenuates amyloid pathology in Alzheimer disease mouse and cell models through facilitating lysosomal degradation of BACE1","volume":"291","author":"Schn\u00f6der","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0065","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly potent and selective Butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112766","article-title":"Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors","volume":"208","author":"Meden","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0075","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-benzyl Benzamide derivatives as selective sub-Nanomolar Butyrylcholinesterase inhibitors for possible treatment in advanced Alzheimer\u2019s disease","volume":"65","author":"Du","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0080","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","article-title":"Discovery and structure\u2013activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening","volume":"59","author":"Dighe","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00826-7","article-title":"An overview of kinase downregulators and recent advances in discovery approaches","volume":"6","author":"Wang","year":"2021","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108998_bb0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.12688\/f1000research.22092.1","article-title":"An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling, F1000Res","volume":"9","author":"Han","year":"2020","journal-title":"F1000 Faculty Rev"},{"key":"10.1016\/j.bioorg.2025.108998_bb0095","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/cmdc.201500030","article-title":"A comprehensive structural overview of p38\u03b1 MAPK in complex with type I inhibitors","volume":"10","author":"Astolfi","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108998_bb0100","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1073\/pnas.1721441115","article-title":"Dynamic activation and regulation of the mitogen-activated protein kinase p38","volume":"115","author":"Kumar","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.108998_bb0105","first-page":"5729","article-title":"The p38 MAPK inhibitors and their role in inflammatory diseases","volume":"6","author":"Machado","year":"2021","journal-title":"Chem. Select"},{"key":"10.1016\/j.bioorg.2025.108998_bb0110","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.bmcl.2010.07.134","article-title":"Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region","volume":"20","author":"Ahn","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108998_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/toxsci\/kfm215","article-title":"Aging pathways for organophosphate-inhibited human Butyrylcholinesterase, including novel pathways for Isomalathion, resolved by mass spectrometry","volume":"100","author":"Li","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bioorg.2025.108998_bb0120","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0021-9258(18)64204-8","article-title":"Carbamyl Derivatives of Acetylcholinesterase","volume":"236","year":"1961","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0125","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and Nanomolar carbamate-based Butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115048","article-title":"Pseudo-irreversible butyrylcholinesterase inhibitors: structure-activity relationships, computational and crystallographic study of the N-dialkyl O-arylcarbamate warhead","volume":"247","author":"Meden","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0135","article-title":"From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series","volume":"234","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0140","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective Butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer\u2019s disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0145","article-title":"Pleiotropic prodrugs: design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer\u2019s disease","volume":"210","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0150","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1016\/j.bmcl.2010.06.073","article-title":"Enhanced selectivity profile of pyrazole-urea based DFG-out p38\u03b1 inhibitors","volume":"20","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108998_bb0155","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.chembiol.2005.08.011","article-title":"Mechanism of carbamate inactivation of FAAH: implications for the Design of Covalent Inhibitors and in Vivo Functional Probes for enzymes","volume":"12","author":"Alexander","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0160","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic carbamates in drug design and medicinal chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.chembiol.2020.07.008","article-title":"Strategies for tuning the selectivity of chemical probes that target serine hydrolases","volume":"27","author":"Faucher","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113705","article-title":"Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: a review","volume":"224","author":"Sabe","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0175","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/acsmedchemlett.1c00662","article-title":"Contemporary computational applications and tools in drug discovery","volume":"13","author":"Cox","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108998_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106390","article-title":"Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro","volume":"135","author":"Mousavi","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0185","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/acschemneuro.4c00055","article-title":"Practical three-component Regioselective synthesis of drug-like 3-aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as potential non-covalent multi-targeting inhibitors to combat neurodegenerative diseases","volume":"15","author":"Mousavi","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2025.108998_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228461","article-title":"Interactive molecular dynamics in virtual reality for accurate flexible protein-ligand docking","volume":"15","author":"Deeks","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108998_bb0195","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/jm020057r","article-title":"Pyrazole urea-based inhibitors of p38 MAP kinase: from Lead compound to clinical candidate","volume":"45","author":"Regan","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0200","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1021\/acsomega.4c10198","article-title":"Development of novel sulfonamide-based Pyrazole-clubbed Pyrazoline derivatives: synthesis, biological evaluation, and molecular docking study","volume":"10","author":"Zala","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108998_bb0205","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1021\/acs.joc.2c00803","article-title":"N-alkyl Carbamoylimidazoles as isocyanate equivalents: exploration of the reaction scope for the synthesis of Ureas, Hydantoins, carbamates, Thiocarbamates, and Oxazolidinones","volume":"87","author":"Bansagi","year":"2022","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0210","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1021\/ja301387k","article-title":"Biomimetic synthesis of the antimalarial Flindersial alkaloids","volume":"134","author":"Vallakati","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108998_bb0215","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1021\/ja00741a013","article-title":"Cyanohydridoborate anion as a selective reducing agent","volume":"93","author":"Borch","year":"1971","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108998_bb0220","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea derivatives in modern drug discovery and medicinal chemistry","volume":"63","author":"Ghosh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/adt.2009.0222","article-title":"ADP-Glo: a bioluminescent and homogeneous ADP monitoring assay for kinases","volume":"7","author":"Zegzouti","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108998_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2025.108998_bb0245","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0250","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.10041","article-title":"Selection criteria for drug-like compounds","volume":"23","author":"Muegge","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108998_bb0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14283\/jpad.2018.43","article-title":"Revisiting the cholinergic hypothesis in Alzheimer\u2019s disease: emerging evidence from translational and clinical research","volume":"6","author":"Hampel","year":"2019","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.bioorg.2025.108998_bb0265","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0163-1047(86)90750-8","article-title":"Scopolamine effects on memory retention in mice: A model of dementia?","volume":"45","year":"1986","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0270","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bioorg.2025.108998_bb0275","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0091-3057(87)90555-7","article-title":"Effects of scopolamine on locomotor activity and metabolic rate in mice","volume":"26","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bioorg.2025.108998_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vascn.2017.04.006","article-title":"Comparison of pro-amnesic efficacy of scopolamine, Biperiden, and phencyclidine by using passive avoidance task in CD-1 mice","volume":"86","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bioorg.2025.108998_bb0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2014.08.002","article-title":"Assessing rodent hippocampal involvement in the novel object recognition task. A review","volume":"285","author":"Cohen","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bioorg.2025.108998_bb0290","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.2174\/1381612819666131216114240","article-title":"The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia","volume":"20","author":"Rajagopal","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2025.108998_bb0295","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.apsb.2023.01.013","article-title":"8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases","volume":"13","author":"Knez","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108998_bb0300","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-induced model of Neuroinflammation: mechanisms of action, Research Application and Future Directions for Its Use","volume":"27","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108998_bb0305","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: pKa and protonation state prediction through machine learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2025.108998_bb0310","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0315","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2025.108998_bb0320","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108998_bb0325","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"Integrated modeling program, applied chemical theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.108998_bb0330","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pharep.2015.04.018","article-title":"The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice","volume":"67","author":"Sa\u0142at","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2025.108998_bb0335","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00210-013-0847-2","article-title":"Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice, Naunyn-Schmiedeberg\u2019s","volume":"386","author":"Sa\u0142at","year":"2013","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108998_bb0340","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pharep.2014.11.003","article-title":"Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression","volume":"67","author":"Sa\u0142at","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2025.108998_bb0345","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:38:34Z","timestamp":1772843914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":69,"alternative-id":["S0045206825008788"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108998","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming ureas into carbamates: From allosteric p38\u03b1 MAPK ligands to dual BChE\/p38\u03b1 MAPK inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108998"}}